[{"address1": "121 Richmond Street West", "address2": "Penthouse Suite, 1300", "city": "Toronto", "state": "ON", "zip": "M5H 2K1", "country": "Canada", "phone": "416-477-1708", "website": "https://psyence.com", "industry": "Drug Manufacturers - General", "industryKey": "drug-manufacturers-general", "industryDisp": "Drug Manufacturers - General", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Psyence Group Inc., a life science biotechnology company, engages in the cultivation and production of commercial psilocybin mushroom. It operates in two segments: Clinical Trial Activities and Non-Clinical Trial Activities. The company natural psilocybin is used for the treatment of a range of mental health disorders and other medical conditions. It also focuses on the development, distribution, and sale of over-the-counter non psilocybin containing functional mushroom nutraceutical products under the GOODMIND brand. The company was founded in 2019 and is based in Toronto, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Jody  Aufrichtig", "age": 50, "title": "Co-Founder & Executive Chairman", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 108308, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Adri  Botha", "title": "Interim Chief Financial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Taryn  Vos", "title": "General Counsel", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tony  Budden", "title": "Chief Strategy Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mary-Elizabeth  Gifford", "title": "Executive Vice President for Public Policy & Global Impact", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.0, "open": 0.006, "dayLow": 0.005, "dayHigh": 0.006, "regularMarketPreviousClose": 0.0, "regularMarketOpen": 0.006, "regularMarketDayLow": 0.005, "regularMarketDayHigh": 0.006, "payoutRatio": 0.0, "beta": 1.297, "volume": 198000, "regularMarketVolume": 198000, "averageVolume": 3821, "averageVolume10days": 22638, "averageDailyVolume10Day": 22638, "bid": 0.005, "ask": 0.022, "bidSize": 0, "askSize": 0, "marketCap": 1079640, "fiftyTwoWeekLow": 0.005, "fiftyTwoWeekHigh": 0.443999, "fiftyDayAverage": 0.17545716, "twoHundredDayAverage": 0.21694928, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": "NaN", "currency": "USD", "tradeable": false, "enterpriseValue": 26983414, "profitMargins": 0.0, "floatShares": 9002375, "sharesOutstanding": 9335410, "heldPercentInsiders": 0.03373, "heldPercentInstitutions": 0.0, "impliedSharesOutstanding": 303063008, "bookValue": -2.559, "lastFiscalYearEnd": 1711843200, "nextFiscalYearEnd": 1743379200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -65831352, "trailingEps": -5.31, "lastSplitFactor": "1:15", "lastSplitDate": 1745366400, "enterpriseToEbitda": -4.631, "52WeekChange": -0.56440514, "SandP52WeekChange": 0.12677538, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "PSYGF", "underlyingSymbol": "PSYGF", "shortName": "Psyence Group Inc.", "longName": "Psyence Group Inc.", "firstTradeDateEpochUtc": 1654003800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "5781b508-51cf-39d5-8fbe-9a540a0551c1", "messageBoardId": "finmb_682094975", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.11565, "recommendationKey": "none", "totalCash": 10559364, "totalCashPerShare": 1.128, "ebitda": -5827268, "totalDebt": 0, "quickRatio": 9.749, "currentRatio": 9.858, "returnOnAssets": -0.52665, "returnOnEquity": -11.54799, "freeCashflow": -3568501, "operatingCashflow": -5711141, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CAD", "trailingPegRatio": null, "__fetch_time": "2025-07-05"}]